Welcome to our dedicated page for DNOW SEC filings (Ticker: DNOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DNOW's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DNOW's regulatory disclosures and financial reporting.
ALARIO RICHARD J reported acquisition or exercise transactions in this Form 4 filing.
DNOW Inc. director Richard J. Alario reported receiving a grant of 17,122 shares of common stock on May 20, 2026. The shares were awarded at a reported price of $0.00 per share, indicating a compensation-related grant rather than a market purchase. Following this award, Alario directly holds 294,169 shares of DNOW common stock, so the grant represents a relatively small addition to his existing position.
JADIN RONALD L reported acquisition or exercise transactions in this Form 4 filing.
DNOW Inc. director Ronald L. Jadin received a stock award of 12,122 shares of common stock on May 20, 2026. The award was reported at a price of $0.00 per share, indicating it was a compensation grant rather than a market purchase. Following this grant, his direct ownership increased to 66,341 common shares.
Bonno Terry reported acquisition or exercise transactions in this Form 4 filing.
DNOW Inc. director Terry Bonno received a stock award of 12,122 shares of common stock on May 20, 2026. The award was recorded at a price of $0.00 per share, indicating it was compensation rather than an open-market purchase. Following this grant, Bonno directly holds 124,994 DNOW common shares.
DNOW Inc. director Paul M. Coppinger received a grant of 12,122 shares of common stock on May 20, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related stock award rather than a market purchase.
After this grant, Coppinger directly owns 78,846 shares of DNOW common stock. The filing does not show any sales or option exercises, only this stock award that increases his direct equity stake.
David-Green Karen reported acquisition or exercise transactions in this Form 4 filing.
DNOW Inc. director Karen David-Green received a stock grant of 12,122 shares of common stock, recorded at no cash price per share. After this award, she directly holds a total of 43,956 DNOW common shares, reflecting a routine compensation-related equity grant rather than an open‑market purchase or sale.
Cobb Galen reported acquisition or exercise transactions in this Form 4 filing.
DNOW Inc. director Galen Cobb received a stock award of 12,122 shares of common stock as compensation, rather than buying them in the market. The award was granted at no cash cost per share. After this grant, Cobb directly holds a total of 122,594 DNOW common shares.
DNOW Inc. director George John Damiris received a grant of 12,122 shares of common stock, recorded at a price of $0.00 per share, as a non-cash award. This compensation-related acquisition increased his direct holdings to 66,341 shares of DNOW common stock.
Reed Sonya reported acquisition or exercise transactions in this Form 4 filing.
DNOW Inc. director Sonya Reed received a stock grant. On May 20, 2026, she was awarded 12,122 shares of DNOW common stock at no cost as a compensation-related grant. Following this award, she directly holds 70,360 shares of DNOW common stock. This is a non-market transaction and does not reflect an open-market purchase or sale.
DNOW Inc. held its Annual Meeting of Stockholders on May 20, 2026, where stockholders voted on directors, auditors, and executive pay. All nine director nominees, including Richard Alario and Sonya Reed, were re-elected to one-year terms expiring in 2027.
Stockholders also ratified KPMG LLP as the independent auditors for 2026, with 170,813,460 votes in favor and minimal opposition. In an advisory vote, stockholders approved the compensation of the company’s named executive officers, with 155,128,968 votes for and 6,013,091 against, confirming support for current pay practices.
NOW Inc. Schedule 13G/A amendment shows affiliated Wellington entities report beneficial ownership of 16,879,174 shares, representing 9.06% of common stock as disclosed in Item 4. The filing lists shared voting power of 13,301,543 and shared dispositive power of 16,879,174 as of 03/31/2026.